- Home
- DYN vs SONO Comparison
DYN vs SONO Comparison
Compare DYN & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYN | SONO |
|---|---|---|
| Founded | 1984 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DYN | SONO |
|---|---|---|
| Price | $19.38 | $18.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 3 |
| Target Price | ★ $40.25 | $17.00 |
| AVG Volume (30 Days) | ★ 3.3M | 1.5M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,443,276,000.00 |
| Revenue This Year | N/A | $4.35 |
| Revenue Next Year | N/A | $7.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.36 | $7.63 |
| 52 Week High | $27.59 | $19.82 |
Technical Indicators
Market Signals| Indicator | DYN | SONO |
|---|---|---|
| Relative Strength Index (RSI) | 47.95 | 57.39 |
| Support Level | $19.20 | $18.52 |
| Resistance Level | $20.80 | $19.82 |
| Average True Range (ATR) | 1.49 | 0.62 |
| MACD | -0.29 | -0.00 |
| Stochastic Oscillator | 20.70 | 57.61 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About SONO Sonos Inc.
Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.